Pharmaceutical News

RSS

Scientists develop novel treatment strategy for multiple myeloma

Scientists at Virginia Commonwealth University Massey Cancer Center have developed a novel treatment strategy for multiple myeloma that pairs two targeted agents to kill cancer cells. The study's findings, published in today's edition of the journal "Blood," are the first to demonstrate the synergistic, anti-myeloma effects of this combination regimen both in vitro and in vivo.

11 Feb 2011

Times of India examines dengue vaccine trials

India could soon become a site for clinical trials to evaluate the effectiveness of a dengue vaccine, the Times of India reports. According to the drug controller general of India, vaccine maker Sanofi Pasteur recently submitted a proposal to test the vaccine to the country.

11 Feb 2011

Preladenant may offer new supplemental treatment for Parkinson's disease: Study

Preladenant, a non-dopaminergic medication, reduces off time in patients with Parkinson's disease receiving standard dopamine therapy, an international study led by the University of South Florida found.

11 Feb 2011

New findings of drug recently identified to prevent stroke in patients with AF published in NEJM

New findings from a McMaster University-led study of a drug recently identified to prevent stroke in patients with atrial fibrillation have been published in the high-impact New England Journal of Medicine today.

11 Feb 2011

Intellikine, PKD Foundation to investigate novel therapies for patients with PKD

Intellikine, a leader in the development of small molecule drugs targeting the PI3K/mTOR pathway, and the PKD Foundation today announced a collaboration to investigate novel, orally-available small molecule kinase inhibitors of the TORC1 and TORC2 complexes as a potential treatment for patients with polycystic kidney disease.

11 Feb 2011

Valeant Pharmaceuticals subsidiary acquires Canadian rights to Cholestagel

Valeant Pharmaceuticals International, Inc. today announced that its subsidiary, Biovail Laboratories International SRL, has acquired the Canadian rights to Cholestagel (colesevelam), an oral bile acid sequestrant for hypercholesterolemia, from Genzyme Corporation.

10 Feb 2011

Global Health Consortium to support development of vaccines to control dengue fever

The International Vaccine Institute today announced the launch of the Dengue Vaccine Initiative, in collaboration with the Sabin Vaccine Institute, the Johns Hopkins University, and the World Health Organization, to support development of vaccines to control dengue fever, a widespread and expanding hemorrhagic fever that is endemic in most tropical and subtropical regions of the world.

10 Feb 2011

FDA grants final approval for Hi-Tech Pharmacal's ANDA for levofloxacin ophthalmic solution

Hi-Tech Pharmacal Co., Inc., a specialty pharmaceuticals company, announced today that the US Food and Drug Administration granted final approval for the Company's Abbreviated New Drug Application for levofloxacin ophthalmic solution, 0.5% the generic for Vistakon's Quixin ophthalmic solution, which had sales of $2 million for the 12 months ended December 2010 according to IMS sales data.

10 Feb 2011

Mallinckrodt receives FDA approval for Fentanyl Transdermal System patch ANDA

Covidien, a leading global provider of healthcare products, today announced that Mallinckrodt Inc., a Covidien company, has received U.S. Food and Drug Administration (FDA) approval of its Abbreviated New Drug Application (ANDA) for its Fentanyl Transdermal System (FTS) patch. Covidien is the largest supplier of controlled pain medications in the United States based on number of prescriptions.

10 Feb 2011

Alexion fourth quarter net product sales of Soliris increases to $156.0 million

Alexion Pharmaceuticals, Inc. today announced financial results for the quarter and year ended December 31, 2010. For the three months ended December 31, 2010, Alexion Pharmaceuticals, Inc. reported net product sales of Soliris® (eculizumab) of $156.0 million, reflecting strong additions of new patients, compared to $110.6 million for the same period in 2009.

10 Feb 2011

FDLI's new Policy Forum takes close look on emerging health care liability issues

The ability of families to sue vaccine producers for faulty design could lead to a rise in litigation and force manufacturers to abandon the market, which, in turn, could cause disastrous public health consequences in the United States, assert Daniel J. Gage, Assistant Director and Alison R. Perencevich, Legislative Assistant, at the American Academy of Pediatrics' Department of Federal Affairs.

10 Feb 2011

Rhabdomyolysis episode at University of Iowa signals a public health crisis

On January 26, 2011, it was reported that 13 University of Iowa football players were affected so severely by rhabdomyolysis that they were hospitalized. Occurrences of rhabdomyolysis—muscle breakdown—are so rare that it suggests an additional causal factor, such as a drug.

10 Feb 2011

Avian flu vaccine stockpiled in 2004 still useful

A stockpiled vaccine designed to fight a strain of avian flu that circulated in 2004 can be combined with a vaccine that matches the current strain of bird flu to protect against a potential pandemic, researchers from Saint Louis University's Center for Vaccine Development have found.

10 Feb 2011

PRA opens new offices in Israel, Ukraine to meet increased demand for services

PRA International, a leading Clinical Research Organization, announces the opening of new offices in Israel and the Ukraine to accommodate the firm's continued global expansion and enhance our offerings for clients.

10 Feb 2011

Florida pain clinic society opposes Gov. Scott's proposal to repeal Prescription Drug Monitoring Program

The Florida Society of Pain Management Providers opposes Governor Scott's proposal to repeal the Prescription Drug Monitoring Program (PDMP). The PDMP system is the single most important weapon in the war on Rx drug abuse, not only in Florida but in the other 42 states where legislators have approved their operation.

10 Feb 2011

UCSD: Medication education can help patients with diabetes better stick to drug treatment plans

Researchers at the Skaggs School of Pharmacy and Pharmaceutical Sciences at the University of California, San Diego say that medication education is a key factor in helping patients with diabetes better stick to their drug treatments plans.

10 Feb 2011

State and federal efforts to monitor drug prescriptions and payments face challenges

The Center For Public Integrity reports on the challenges Medicare faces in trying to ensure that prescription drugs paid for by its contracting health plans are actually prescribed by doctors. Meanwhile, The Miami Herald chronicles the latest chapter in the ongoing story about the state's pill mills.

10 Feb 2011

US District Court rules in favor of Watson in generic Mucinex patent infringement suit

Watson Pharmaceuticals, Inc., a leading specialty pharmaceutical company, announced today that the United States District Court for the Southern District of Florida has ruled that Watson's generic versions of Mucinex®, Mucinex® D and Mucinex® DM (Guaifenesin, Dextromethorphan HBr/ Guaifenesin, and Pseudoephedrine/Guaifenesin) Extended-Release products, do not infringe U.S. Patent No. 6,372,252.

10 Feb 2011

Physicist creates technology that may enhance pharma industry's early drug discovery capabilities

A Purdue physicist has created technology to detect motion inside three-dimensional tumor spheroids, which may enhance the pharmaceutical industry's early drug discovery capabilities.

10 Feb 2011

Research shows no protective effect of folate intake against spontaneous preterm delivery

In a study to be presented today at the Society for Maternal-Fetal Medicine's (SMFM) annual meeting, The Pregnancy Meeting -, in San Francisco, researchers will present findings that show that folate intake before and during pregnancy does not protect Norwegian women against spontaneous preterm delivery.

10 Feb 2011

Pharmaceutical News

Scientists develop novel treatment strategy for multiple myeloma

Times of India examines dengue vaccine trials

Preladenant may offer new supplemental treatment for Parkinson's disease: Study

New findings of drug recently identified to prevent stroke in patients with AF published in NEJM

Intellikine, PKD Foundation to investigate novel therapies for patients with PKD

Valeant Pharmaceuticals subsidiary acquires Canadian rights to Cholestagel

Global Health Consortium to support development of vaccines to control dengue fever

FDA grants final approval for Hi-Tech Pharmacal's ANDA for levofloxacin ophthalmic solution

Mallinckrodt receives FDA approval for Fentanyl Transdermal System patch ANDA

Alexion fourth quarter net product sales of Soliris increases to $156.0 million

FDLI's new Policy Forum takes close look on emerging health care liability issues

Rhabdomyolysis episode at University of Iowa signals a public health crisis

Avian flu vaccine stockpiled in 2004 still useful

PRA opens new offices in Israel, Ukraine to meet increased demand for services

Florida pain clinic society opposes Gov. Scott's proposal to repeal Prescription Drug Monitoring Program

UCSD: Medication education can help patients with diabetes better stick to drug treatment plans

State and federal efforts to monitor drug prescriptions and payments face challenges

US District Court rules in favor of Watson in generic Mucinex patent infringement suit

Physicist creates technology that may enhance pharma industry's early drug discovery capabilities

Research shows no protective effect of folate intake against spontaneous preterm delivery

Advancing brain microphysiological systems (bMPS)

PhD researcher at LifeArc

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

Latest News